Mindset Pharma Inc. (MSSTF)

0.2122 -0.0028 (-1.28%) At close: 01:21PM EST

Mindset Pharma Inc.

217 Queen Street West
Suite 401
Toronto, ON M5V 0R2
Canada

https://www.mindsetpharma.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. James Andre-Charles Lanthier	Chief Exec. Officer	357.8k	37.46k	1975
Mr. Arvin Ramos CPA	Chief Financial Officer	87.69k	N/A	1979
Mr. Joseph Araujo	Chief Scientific Officer, Member of Scientific Advisory Board & Director	258.72k	N/A	1977
Mr. Jason Atkinson	VP of Corp. Devel.	112.44k	N/A	1988
Dr. Abdelmalik Slassi Ph.D.	Sr. VP of Innovation & Member of Scientific Advisory Board	352.29k	N/A	N/A
Chris Irwin	Corp. Sec.	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.

Corporate governance

Mindset Pharma Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.